A smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient has been developed by researchers. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1OWxXwi
No comments:
Post a Comment